Tyra Biosciences, Inc. Public Float
Tyra Biosciences, Inc. (TYRA) had Public Float of $297.30 million as of 2025-06-30, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-02
- 2025-06-30: Entity Public Float $297.30M.
- 2024-06-28: Entity Public Float $337.80M.
- 2023-06-30: Entity Public Float $267.40M.
- 2022-06-30: Entity Public Float $121.80M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $297.30M 10-K · filed 2026-03-02 |
| 2024-06-28 | $337.80M 10-K · filed 2025-03-27 |
| 2023-06-30 | $267.40M 10-K · filed 2024-03-19 |
| 2022-06-30 | $121.80M 10-K · filed 2023-03-22 |
| 2021-09-30 | $299.00M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |